Product
Alpha-1 MP
Aliases
Prolastin-C
2 clinical trials
1 indication
Indication
Alpha-1 Antitrypsin DeficiencyClinical trial
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin DeficiencyStatus: Active (not recruiting), Estimated PCD: 2026-08-01